Stay updated on Zenocutuzumab Clinical Trial in NRG1 Fusion
Sign up to get notified when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.
Latest updates to the Zenocutuzumab Clinical Trial in NRG1 Fusion page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe website has been updated to version 2.12.2, replacing the previous estimated update version 2.12.1.SummaryDifference0.1%
- Check32 days agoChange DetectedThe website has been updated to version v2.12.1 as of October 31, 2024, with the last update posted on October 30, while previous contact information and the earlier version v2.12.0 have been removed.SummaryDifference0.7%
- Check39 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
- Check53 days agoChange DetectedThe latest update includes new patient populations and detailed monitoring criteria for a study on zenocutuzumab (MCLA-128), while previous entries regarding specific patient groups and response assessments have been removed.SummaryDifference2%
- Check61 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check68 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.SummaryDifference0.7%
Stay in the know with updates to Zenocutuzumab Clinical Trial in NRG1 Fusion
Enter your email address, and we'll notify you when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.